Meinrad Gawaz

Title: Innovations and Contributions of Meinrad Gawaz

Introduction

Meinrad Gawaz is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biomedical research, particularly in the development of anti-thrombotic agents. With a total of three patents to his name, Gawaz has demonstrated a commitment to advancing medical science and improving patient outcomes.

Latest Patents

Gawaz's latest patents include groundbreaking inventions that focus on cardiovascular health. One of his notable patents is for antibodies that bind to epitopes of glycoprotein VI. This invention provides anti-thrombotic agents, methods for screening these agents, and methods for treating thrombotic and other cardiovascular disorders. Another significant patent is for an immunoadhesin comprising a glycoprotein VI domain. This fusion protein includes the extracellular domain of glycoprotein VI, which is functional for binding to collagen, and the Fc domain of immunoglobulin, characterized by a specific polypeptide chain.

Career Highlights

Throughout his career, Meinrad Gawaz has worked with esteemed organizations such as Trigen GmbH and Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to innovative research projects.

Collaborations

Gawaz has collaborated with notable colleagues, including Andreas Bültmann and Götz Münch. These partnerships have further enriched his research and development efforts, leading to advancements in medical technology.

Conclusion

Meinrad Gawaz's contributions to the field of biomedical research through his patents and collaborations highlight his dedication to innovation. His work continues to impact the medical community positively, paving the way for future advancements in cardiovascular treatment.